Schoergenhofer, Christian <br/><br/>
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.  [electronic resource] 

 -  Scientific reports  07 2019 
 - 11136 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-019-47630-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Coagulation--drug effects<br/>C-Reactive Protein--metabolism<br/>Cross-Over Studies<br/>Cytokines--metabolism<br/>Double-Blind Method<br/>Endotoxemia--drug therapy<br/>Female<br/>Fibrinolysin--metabolism<br/>Fibrinolysis--drug effects<br/>Fibrinolytic Agents--therapeutic use<br/>Healthy Volunteers<br/>Humans<br/>Lipopolysaccharides--administration & dosage<br/>Male<br/>Polydeoxyribonucleotides--therapeutic use<br/>Young Adult<br/>alpha-2-Antiplasmin--metabolism